IL73893A - 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL73893A IL73893A IL73893A IL7389384A IL73893A IL 73893 A IL73893 A IL 73893A IL 73893 A IL73893 A IL 73893A IL 7389384 A IL7389384 A IL 7389384A IL 73893 A IL73893 A IL 73893A
- Authority
- IL
- Israel
- Prior art keywords
- aryl
- processes
- preparation
- same
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229940083712 aldosterone antagonist Drugs 0.000 abstract 1
- 230000001327 anti-mineralocorticoid effect Effects 0.000 abstract 1
- 239000003418 antiprogestin Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000002394 mineralocorticoid antagonist Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
- C07F7/0827—Syntheses with formation of a Si-C bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/006—Ketals at position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833347126 DE3347126A1 (de) | 1983-12-22 | 1983-12-22 | 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL73893A0 IL73893A0 (en) | 1985-03-31 |
| IL73893A true IL73893A (en) | 1993-01-31 |
Family
ID=6218184
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL73893A IL73893A (en) | 1983-12-22 | 1984-12-21 | 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4609651A (no) |
| EP (1) | EP0147361B1 (no) |
| JP (1) | JPS60226893A (no) |
| AT (1) | ATE40696T1 (no) |
| AU (1) | AU573294B2 (no) |
| CA (1) | CA1308095C (no) |
| DD (1) | DD229132A5 (no) |
| DE (2) | DE3347126A1 (no) |
| DK (1) | DK161708C (no) |
| ES (1) | ES538757A0 (no) |
| FI (1) | FI81588C (no) |
| GR (1) | GR82548B (no) |
| HU (1) | HU191739B (no) |
| IE (1) | IE57834B1 (no) |
| IL (1) | IL73893A (no) |
| NO (1) | NO161498C (no) |
| NZ (1) | NZ210627A (no) |
| PT (1) | PT79735A (no) |
| ZA (1) | ZA8410021B (no) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8502612A1 (es) * | 1983-06-15 | 1985-02-01 | Schering Ag | Procedimiento para la preparacion de 13a-alquilgonanos |
| DE3506785A1 (de) * | 1985-02-22 | 1986-08-28 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE3531903A1 (de) * | 1985-09-05 | 1987-03-12 | Schering Ag | Oxytocin und antigestagen zur einleitung der geburt bzw. zum therapeutischen abbruch der graviditaet |
| DE3533175A1 (de) * | 1985-09-13 | 1987-03-19 | Schering Ag | Antigestagene zur verschiebung der endometrialen reifung |
| DE3625315A1 (de) * | 1986-07-25 | 1988-01-28 | Schering Ag | 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate |
| DE3633244A1 (de) * | 1986-09-26 | 1988-03-31 | Schering Ag | Antigestagene zur hemmung der uterinen prostaglandinsynthese |
| US5272140A (en) * | 1987-01-23 | 1993-12-21 | Akzo N.V. | 11-aryl steroid derivatives |
| DE3866410D1 (de) * | 1987-04-24 | 1992-01-09 | Akzo Nv | 11-arylestranderivate und 11-arylpregnanderivate. |
| AU625450B2 (en) * | 1987-07-16 | 1992-07-09 | Schering Aktiengesellschaft Berlin Und Bergkamen | 11beta-phenyl-4,9,15-estratrienes, their manufacture, and pharmaceutical preparations containing them |
| DE3723788A1 (de) * | 1987-07-16 | 1989-01-26 | Schering Ag | 11(beta)-phenyl-4,9,15-estratriene, deren herstellung und diese enthaltende pharmazeutische praeparate |
| FR2620707B1 (fr) * | 1987-09-18 | 1989-12-08 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
| ES2053714T3 (es) * | 1987-12-12 | 1994-08-01 | Akzo Nv | Proceso para la preparacion de 11-arilesteroides. |
| BE1004905A4 (fr) * | 1987-12-30 | 1993-02-23 | Roussel Uclaf | Nouveaux derives 17beta-oh 19-nor steroides substitues en 17alpha, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant. |
| ES2127181T3 (es) * | 1989-08-04 | 1999-04-16 | Schering Ag | 11-beta-aril-gona-4,9-dien-3-onas. |
| FR2650748B1 (fr) * | 1989-08-08 | 1991-11-08 | Roussel Uclaf | Nouveaux esters d'acides organiques avec des alcools derives de 19-nor steroides et leurs sels, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions les renfermant |
| US5276023A (en) * | 1989-08-08 | 1994-01-04 | Roussel Uclaf | 19-nor-steroid esters |
| FR2654337B1 (fr) * | 1989-11-15 | 1994-08-05 | Roussel Uclaf | Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant. |
| US5407928A (en) * | 1990-08-15 | 1995-04-18 | Schering Aktiengesellschaft | 11β-aryl-gona-4,9-dien-3-ones |
| DE4042005A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | D-homo-(16-en)-11(beta)-aryl-4-estrene |
| US5214035A (en) * | 1992-04-16 | 1993-05-25 | Hoechst-Roussel Agri-Vet Company | Thixotropic formulations |
| US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| US5681817A (en) | 1994-02-04 | 1997-10-28 | The Medical College Of Hampton Roads | Treatment of ovarian estrogen dependent conditions |
| CA2149496C (en) * | 1994-05-19 | 2006-12-19 | Ronald Gebhard | 11,21-bisphenyl-19-norpregnane derivatives |
| DE4434488A1 (de) * | 1994-09-14 | 1996-03-21 | Schering Ag | Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
| US5521166A (en) * | 1994-12-19 | 1996-05-28 | Ortho Pharmaceitical Corporation | Antiprogestin cyclophasic hormonal regimen |
| US6020328A (en) | 1998-03-06 | 2000-02-01 | Research Triangle Institute | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US5962444A (en) * | 1998-05-29 | 1999-10-05 | Research Triangle Institute | 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US6262042B1 (en) | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| US7410964B2 (en) * | 2003-05-16 | 2008-08-12 | Merck Sharp & Dohme Ltd. | Cyclohexyl sulphones as gamma-secretase inhibitors |
| SI3263112T1 (sl) | 2006-10-24 | 2020-10-30 | Allergan Pharmaceuticals International Limited | Sestavki in metode za zaviranje endometrijskih proliferacij |
| DE102006054535A1 (de) * | 2006-11-15 | 2008-05-21 | Bayer Schering Pharma Aktiengesellschaft | Progesteronrezeptorantagonisten |
| EP2253641A2 (en) * | 2007-05-01 | 2010-11-24 | Sicor, Inc. | A process for preparing drospirenone and intermediate thereof |
| TWI539953B (zh) | 2008-04-28 | 2016-07-01 | 瑞波若斯治療學公司 | 用於治療乳癌之組成物和方法 |
| DE102009034362A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034367A1 (de) * | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
| DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
| DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
| KR102166867B1 (ko) | 2010-03-22 | 2020-10-19 | 앨러간 파마슈티컬스 인터내셔널 리미티드 | 항프로게스틴의 비독성 전달을 위한 조성물들과 그 방법들 |
| FR3055626B1 (fr) * | 2016-09-08 | 2018-10-12 | Hra Pharma Lab | Procede de synthese d'un compose steroide comprenant un substituant n-methylaniline en position 11 |
| FR3055627A1 (fr) * | 2016-09-08 | 2018-03-09 | Laboratoire Hra-Pharma | Methode de preparation du compose cdb-3877 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2377418A1 (fr) * | 1977-01-13 | 1978-08-11 | Roussel Uclaf | Nouveaux derives steroides 4,9-dieniques 11b-substitues, leur procede de preparation et leur application comme medicaments |
| ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
| DE3130644A1 (de) * | 1981-07-29 | 1983-02-17 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue androstan-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die diese verbindungen enthalten |
| FR2522328B1 (fr) * | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
| DE3461090D1 (en) * | 1983-02-18 | 1986-12-04 | Schering Ag | 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them |
-
1983
- 1983-12-22 DE DE19833347126 patent/DE3347126A1/de not_active Withdrawn
-
1984
- 1984-12-18 DE DE8484730147T patent/DE3476665D1/de not_active Expired
- 1984-12-18 EP EP84730147A patent/EP0147361B1/de not_active Expired
- 1984-12-18 AT AT84730147T patent/ATE40696T1/de active
- 1984-12-18 ES ES538757A patent/ES538757A0/es active Granted
- 1984-12-19 DD DD84271168A patent/DD229132A5/de not_active IP Right Cessation
- 1984-12-19 NZ NZ210627A patent/NZ210627A/xx unknown
- 1984-12-20 FI FI845066A patent/FI81588C/fi not_active IP Right Cessation
- 1984-12-20 AU AU37013/84A patent/AU573294B2/en not_active Ceased
- 1984-12-20 GR GR82548A patent/GR82548B/el unknown
- 1984-12-21 US US06/685,088 patent/US4609651A/en not_active Expired - Fee Related
- 1984-12-21 JP JP59268686A patent/JPS60226893A/ja active Granted
- 1984-12-21 DK DK623784A patent/DK161708C/da not_active IP Right Cessation
- 1984-12-21 HU HU844805A patent/HU191739B/hu not_active IP Right Cessation
- 1984-12-21 PT PT79735A patent/PT79735A/pt not_active IP Right Cessation
- 1984-12-21 IL IL73893A patent/IL73893A/xx not_active IP Right Cessation
- 1984-12-21 ZA ZA8410021A patent/ZA8410021B/xx unknown
- 1984-12-21 IE IE3293/84A patent/IE57834B1/en not_active IP Right Cessation
- 1984-12-21 NO NO845195A patent/NO161498C/no unknown
- 1984-12-21 CA CA000470847A patent/CA1308095C/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| FI81588C (fi) | 1990-11-12 |
| FI845066L (fi) | 1985-06-23 |
| ZA8410021B (en) | 1985-08-28 |
| HU191739B (en) | 1987-04-28 |
| EP0147361A2 (de) | 1985-07-03 |
| AU3701384A (en) | 1985-07-04 |
| HUT36840A (en) | 1985-10-28 |
| FI81588B (fi) | 1990-07-31 |
| JPS60226893A (ja) | 1985-11-12 |
| EP0147361A3 (en) | 1986-03-26 |
| NO161498B (no) | 1989-05-16 |
| US4609651A (en) | 1986-09-02 |
| IE57834B1 (en) | 1993-04-21 |
| CA1308095C (en) | 1992-09-29 |
| DK161708C (da) | 1992-01-20 |
| GR82548B (en) | 1985-04-08 |
| DE3476665D1 (en) | 1989-03-16 |
| DD229132A5 (de) | 1985-10-30 |
| EP0147361B1 (de) | 1989-02-08 |
| FI845066A0 (fi) | 1984-12-20 |
| IL73893A0 (en) | 1985-03-31 |
| DK623784A (da) | 1985-06-23 |
| DK161708B (da) | 1991-08-05 |
| ATE40696T1 (de) | 1989-02-15 |
| ES8600772A1 (es) | 1985-11-01 |
| NZ210627A (en) | 1988-06-30 |
| PT79735A (de) | 1985-01-01 |
| IE843293L (en) | 1985-06-22 |
| AU573294B2 (en) | 1988-06-02 |
| NO161498C (no) | 1989-08-23 |
| DE3347126A1 (de) | 1985-07-11 |
| DK623784D0 (da) | 1984-12-21 |
| JPH0559918B2 (no) | 1993-09-01 |
| NO845195L (no) | 1985-06-24 |
| ES538757A0 (es) | 1985-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL73893A (en) | 11-aryl-13-estradiene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
| TW334418B (en) | Stilbene derivatives and pharmaceutical compositions | |
| IL76457A0 (en) | Tetralin derivatives,their preparation and pharmaceutical compositions containing them | |
| PT79839A (en) | Process for the preparation of 6,6-ethylene-15,16-methylene-3-oxi-17alpha-pregn-4-ene-21,17-carbolactones and pharmaceutical compositions therewith | |
| ES8702379A1 (es) | Un procedimiento para la produccion de 1h-tetrazol-5-carboxamidas-n-sustituidas. | |
| DE3269533D1 (en) | New quinolylacetic acid compounds and pharmaceutical compositions containing them | |
| IL60176A (en) | (aminopiperidinopropyl)dimethyl xanthine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them | |
| ES2049186A1 (es) | Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol. | |
| ES8201993A1 (es) | Un procedimiento para la preparacion de tiazoles | |
| ES467886A1 (es) | Procedimiento para la preparacion de derivados de acido oleanoico. | |
| JPS52100470A (en) | Synthesis of hydantoin derivatives | |
| NZ211846A (en) | 2,3-diamino-2,3-didesoxyhexose derivatives and pharmaceutical compositions thereof | |
| GR3000773T3 (en) | 2,2;6,6-diethylene-3-oxo-17-alpha-pregn-4-ene-21,17-carbolactones, process for their preparation and pharmaceutical compositions containing them | |
| NZ218918A (en) | 4-oxo-1,4-dihydro-quinoline 3-carboxamides,their preparation and pharmaceutical compositions containing them | |
| ES8300752A1 (es) | "un procedimiento para la preparacion de derivados de n-ftalidil-5-fluorouracilo". |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| RH1 | Patent not in force |